{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:13:05Z","timestamp":1789992785045,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10557-022-07387-z","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T06:02:57Z","timestamp":1664949777000},"page":"297-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3763-3971","authenticated-orcid":false,"given":"Andres","family":"Cordova Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzam","family":"Khokhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle A.","family":"Olonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Carhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"issue":"1","key":"7387_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/rheumatology\/kes353","volume":"52","author":"JA Avina-Zubieta","year":"2013","unstructured":"Avina-Zubieta JA, Abrahamowicz M, De Vera MA, Choi HK, Sayre EC, Rahman MM, et al. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatol (Oxford). 2013;52(1):68\u201375.","journal-title":"Rheumatol (Oxford)"},{"issue":"9","key":"7387_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107(9):1303\u20137.","journal-title":"Circulation"},{"issue":"12","key":"7387_CR3","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID del Rinc\u00f3n","year":"2001","unstructured":"del Rinc\u00f3n ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44(12):2737\u201345.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"7387_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69(2):325\u201331.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"7387_CR5","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1136\/ard.2009.122226","volume":"69","author":"DH Solomon","year":"2010","unstructured":"Solomon DH, Kremer J, Curtis JR, Hochberg MC, Reed G, Tsao P, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010;69(11):1920\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7387_CR6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/rheumatology\/ker338","volume":"51","author":"HL Wright","year":"2012","unstructured":"Wright HL, Bucknall RC, Moots RJ, Edwards SW. Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatol (Oxford). 2012;51(3):451\u20139.","journal-title":"Rheumatol (Oxford)"},{"issue":"9313","key":"7387_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","volume":"359","author":"HK Choi","year":"2002","unstructured":"Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359(9313):1173\u20137.","journal-title":"Lancet"},{"issue":"3","key":"7387_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/acr.22166","volume":"66","author":"A Bili","year":"2014","unstructured":"Bili A, Tang X, Pranesh S, Bozaite R, Morris SJ, Antohe JL, et al. Tumor necrosis factor \u03b1 inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014;66(3):355\u201363.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"7387_CR9","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1002\/art.22809","volume":"56","author":"WG Dixon KD Watson M Lunt Hyrich KL Rheumatology Biologics Register Control Centre C, Silman AJ et al","year":"2007","unstructured":"WG Dixon KD Watson M Lunt Hyrich KL Rheumatology Biologics Register Control Centre C, Silman AJ et al. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2007;56(9):2905\u201312.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"7387_CR10","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/0026-0495(91)90064-4","volume":"40","author":"G Paolisso","year":"1991","unstructured":"Paolisso G, Valentini G, Giugliano D, Marrazzo G, Tirri R, Gallo M, et al. Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. Metabolism. 1991;40(9):902\u20137.","journal-title":"Metabolism"},{"issue":"Suppl 2","key":"7387_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2337\/diab.41.2.S97","volume":"41","author":"KR Feingold","year":"1992","unstructured":"Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes. 1992;41(Suppl 2):97\u2013101.","journal-title":"Diabetes"},{"issue":"1","key":"7387_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/art.10748","volume":"48","author":"M Wong","year":"2003","unstructured":"Wong M, Toh L, Wilson A, Rowley K, Karschimkus C, Prior D, et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum. 2003;48(1):81\u20139.","journal-title":"Arthritis Rheum"},{"issue":"17","key":"7387_CR13","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","volume":"106","author":"D Hurlimann","year":"2002","unstructured":"Hurlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002;106(17):2184\u20137.","journal-title":"Circulation"},{"issue":"6","key":"7387_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/rheumatology\/40.6.640","volume":"40","author":"A McEntegart","year":"2001","unstructured":"McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatol (Oxford). 2001;40(6):640\u20134.","journal-title":"Rheumatol (Oxford)"},{"issue":"5","key":"7387_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s10067-007-0550-0","volume":"26","author":"F Wang","year":"2007","unstructured":"Wang F, Wang NS, Yan CG, Li JH, Tang LQ. The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol. 2007;26(5):768\u201371.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"7387_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/rheumatology\/kep377","volume":"49","author":"PA Mac Mullan","year":"2010","unstructured":"Mac Mullan PA, Peace AJ, Madigan AM, Tedesco AF, Kenny D, McCarthy GM. Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: a novel finding and potential therapeutic target. Rheumatol (Oxford). 2010;49(2):240\u20135.","journal-title":"Rheumatol (Oxford)"},{"key":"7387_CR17","doi-asserted-by":"publisher","unstructured":"Sharma TS, Wasko MC, Tang X, Vedamurthy D, Yan X, Cote J, Bili A. Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients. J Am Heart Assoc. 2016;5(1):e002867. https:\/\/doi.org\/10.1161\/JAHA.115.002867","DOI":"10.1161\/JAHA.115.002867"},{"issue":"5","key":"7387_CR18","doi-asserted-by":"publisher","first-page":"e13095","DOI":"10.1111\/ijcp.13095","volume":"72","author":"YM Hung","year":"2018","unstructured":"Hung YM, Wang YH, Lin L, Wang PYP, Chiou JY, Wei JC. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: a nationwide population-based cohort study. Int J Clin Pract. 2018;72(5):e13095.","journal-title":"Int J Clin Pract"},{"issue":"11","key":"7387_CR19","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1016\/S2665-9913(20)30276-9","volume":"2","author":"JCE Lane","year":"2020","unstructured":"Lane JCE, Weaver J, Kostka K, Duarte-Salles T, Abrahao MTF, Alghoul H, et al. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. 2020;2(11):e698\u2013711.","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"7387_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jacc.2022.04.039","volume":"80","author":"E D'Andrea","year":"2022","unstructured":"D\u2019Andrea E, Desai RJ, He M, Glynn RJ, Lee H, Weinblatt ME, et al. Cardiovascular risks of hydroxychloroquine vs methotrexate in patients with rheumatoid arthritis. J Am Coll Cardiol. 2022;80(1):36\u201346.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"7387_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cmet.2006.10.002","volume":"4","author":"JG Schneider","year":"2006","unstructured":"Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab. 2006;4(5):377\u201389.","journal-title":"Cell Metab"},{"issue":"2","key":"7387_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.bbrc.2004.12.026","volume":"327","author":"KY Kim","year":"2005","unstructured":"Kim KY, Kim JK, Jeon JH, Yoon SR, Choi I, Yang Y. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2005;327(2):460\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"7387_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nm1111","volume":"10","author":"H Kaneto","year":"2004","unstructured":"Kaneto H, Nakatani Y, Miyatsuka T, Kawamori D, Matsuoka TA, Matsuhisa M, et al. Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat Med. 2004;10(10):1128\u201332.","journal-title":"Nat Med"},{"issue":"5701","key":"7387_CR24","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1126\/science.1101909","volume":"306","author":"R Ricci","year":"2004","unstructured":"Ricci R, Sumara G, Sumara I, Rozenberg I, Kurrer M, Akhmedov A, et al. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science. 2004;306(5701):1558\u201361.","journal-title":"Science"},{"issue":"9","key":"7387_CR25","doi-asserted-by":"publisher","first-page":"e0139226","DOI":"10.1371\/journal.pone.0139226","volume":"10","author":"AM Shukla","year":"2015","unstructured":"Shukla AM, Bose C, Karaduta OK, Apostolov EO, Kaushal GP, Fahmi T, et al. Impact of hydroxychloroquine on atherosclerosis and vascular stiffness in the presence of chronic kidney disease. PLoS One. 2015;10(9):e0139226.","journal-title":"PLoS One"},{"issue":"1","key":"7387_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/annrheumdis-2017-211836","volume":"77","author":"C Rempenault","year":"2018","unstructured":"Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, et al. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2018;77(1):98\u2013103.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7387_CR27","doi-asserted-by":"publisher","first-page":"R135","DOI":"10.1186\/ar3868","volume":"14","author":"E Mercer","year":"2012","unstructured":"Mercer E, Rekedal L, Garg R, Lu B, Massarotti EM, Solomon DH. Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals. Arthritis Res Ther. 2012;14(3):R135.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"7387_CR28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.7326\/0003-4819-112-9-678","volume":"112","author":"A Quatraro","year":"1990","unstructured":"Quatraro A, Consoli G, Magno M, Caretta F, Nardozza A, Ceriello A, et al. Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus A new job for an old drug? Ann Intern Med. 1990;112(9):678\u201381.","journal-title":"Ann Intern Med"},{"issue":"12","key":"7387_CR29","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2337\/diab.33.12.1133","volume":"33","author":"BR Blazar","year":"1984","unstructured":"Blazar BR, Whitley CB, Kitabchi AE, Tsai MY, Santiago J, White N, et al. In vivo chloroquine-induced inhibition of insulin degradation in a diabetic patient with severe insulin resistance. Diabetes. 1984;33(12):1133\u20137.","journal-title":"Diabetes"},{"issue":"1","key":"7387_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/07435808709023662","volume":"13","author":"K Sorimachi","year":"1987","unstructured":"Sorimachi K, Okayasu T, Yasumura Y. Increase in insulin binding affinity by chloroquine in cultured rat hepatoma cells. Endocr Res. 1987;13(1):49\u201360.","journal-title":"Endocr Res"},{"issue":"3","key":"7387_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0168-8227(90)90056-Y","volume":"9","author":"KA Asamoah","year":"1990","unstructured":"Asamoah KA, Robb DA, Furman BL. Chronic chloroquine treatment enhances insulin release in rats. Diabetes Res Clin Pract. 1990;9(3):273\u20138.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"7387_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1074248414546324","volume":"20","author":"S Achuthan","year":"2015","unstructured":"Achuthan S, Ahluwalia J, Shafiq N, Bhalla A, Pareek A, Chandurkar N, et al. Hydroxychloroquine\u2019s Efficacy as an antiplatelet agent study in healthy volunteers: a proof of concept study. J Cardiovasc Pharmacol Ther. 2015;20(2):174\u201380.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"11","key":"7387_CR33","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.1016\/S0021-9258(19)70769-8","volume":"255","author":"Y Matsuzawa","year":"1980","unstructured":"Matsuzawa Y, Hostetler KY. Inhibition of lysosomal phospholipase A and phospholipase C by chloroquine and 4,4\u2019-bis(diethylaminoethoxy) alpha, beta-diethyldiphenylethane. J Biol Chem. 1980;255(11):5190\u20134.","journal-title":"J Biol Chem"},{"issue":"3","key":"7387_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1172\/JCI1052","volume":"102","author":"D Ghigo","year":"1998","unstructured":"Ghigo D, Aldieri E, Todde R, Costamagna C, Garbarino G, Pescarmona G, et al. Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells. J Clin Invest. 1998;102(3):595\u2013605.","journal-title":"J Clin Invest"},{"issue":"6","key":"7387_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/rheumatology\/kei282","volume":"45","author":"CH Jang","year":"2006","unstructured":"Jang CH, Choi JH, Byun MS, Jue DM. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes\/macrophages by different modes. Rheumatol (Oxford). 2006;45(6):703\u201310.","journal-title":"Rheumatol (Oxford)"},{"issue":"12","key":"7387_CR36","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"1","key":"7387_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/acr.23826","volume":"72","author":"C Rempenault","year":"2020","unstructured":"Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, et al. Clinical and structural efficacy of hydroxychloroquine in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken). 2020;72(1):36\u201340.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"7387_CR38","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","volume":"41","author":"C Chatre","year":"2018","unstructured":"Chatre C, Roubille F, Vernhet H, Jorgensen C, Pers YM. Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature. Drug Saf. 2018;41(10):919\u201331.","journal-title":"Drug Saf"},{"issue":"9","key":"7387_CR39","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","volume":"5","author":"NJ Mercuro","year":"2020","unstructured":"Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(9):1036\u201341.","journal-title":"JAMA Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-022-07387-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-022-07387-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-022-07387-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:08:42Z","timestamp":1744157322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-022-07387-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["7387"],"URL":"https:\/\/doi.org\/10.1007\/s10557-022-07387-z","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"25 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study was not required since all data was obtained from a de-identified database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent and Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}